查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654642

全球电穿孔仪器市场 - 2025 至 2033 年

Global Electroporation Instruments Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 159 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球电穿孔仪器市场规模达到 2.5142 亿美元，预计到 2033 年将达到 3.7404 亿美元，2025-2033 年预测期内的复合年增长率为 4.5%。

电穿孔仪器是用于促进电穿孔的设备，电穿孔是一种向细胞施加短电脉衝以暂时增加其膜通透性的技术。这使得 DNA、RNA、蛋白质或药物等物质能够被引入细胞，而这个过程对于生物技术、基因工程和医学中的各种应用至关重要。电穿孔广泛应用于基因研究、药物传递、疫苗接种和蛋白质生产，因为与传统方法相比，它允许分子物质更有效、更直接地转移到细胞中。这些仪器因其精确度、有效性以及处理多种细胞类型（包括真核细胞和原核细胞）的能力而受到高度重视。

受生物技术进步、研究活动的增加以及基因编辑和治疗应用需求不断增长的推动，电穿孔仪器市场正在经历显着增长。例如，2024年6月，博腾生物将MaxCyte cGMP级ExPERT GTx流式电穿孔仪引入其细胞治疗平台，标誌着该公司成为中国第一家拥有该临床级流式电穿孔系统的细胞治疗CDMO。

市场动态：

驱动因素与约束因素

科技进步日新月异

不断进步的技术极大地推动了电穿孔仪器市场的成长，并预计在预测期内推动市场的发展。电穿孔已成为癌症治疗的关键技术，尤其是透过电化学疗法。该方法包括向肿瘤施加电脉衝，增加细胞膜通透性并允许化疗药物更有效地进入癌细胞。技术进步提高了该技术的精确度和安全性，为皮肤和皮下肿瘤患者带来了更好的治疗效果。

例如，2024 年 10 月，AngioDynamics 与伦敦大学学院医院 (UCLH) 合作启动了一项前瞻性註册研究，评估奈米刀系统治疗单灶中危前列腺癌的长期效果。此奈米刀系统使用不可逆电穿孔技术来治疗肿瘤，透过传递高压电脉衝在细胞膜上产生微小孔隙，从而导致可控细胞死亡，而不会损害周围组织。

CRISPR-Cas9等基因编辑技术的发展增加了对电穿孔仪器的需求。电穿孔有助于将基因编辑成分有效地递送到细胞中，从而推动研究和治疗应用。这导致电穿孔仪器在基因工程和治疗干预中的应用激增。

电穿孔仪器成本高

电穿孔仪器的高成本限制了其可及性和采用率，严重阻碍了市场的成长，尤其是对于预算有限的小型实验室和研究机构。例如，新型电穿孔系统的成本通常在 3,000 美元到 20,000 美元之间，具体取决于型号、特性和能力。

电穿孔仪器的价格昂贵，只有资金充足的实验室和研究中心才能购买，而较小的机构则无法投资此类技术。这种差异导致无法平等地获得先进的研究工具，阻碍了市场的整体成长。高昂的设备成本可能导致研究项目和新疗法开发的延迟，因为机构可能缺乏采购和维护这些仪器所需的资源。研究活动的放缓可能会阻碍该领域的科学进步和创新。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分类的片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 不断进步的技术
    • 限制
      • 电穿孔仪器成本高
    • 机会
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • 新兴创业公司和关键创新者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态

第 5 章：电穿孔仪器市场（依产品类型）

  • 仪器
    • 全电穿孔系统
    • 真核电穿孔系统
    • 微生物电穿孔系统
  • 配件
    • 电穿孔比色皿
    • 电极
    • 钱伯斯
    • 套件
    • 其他的

第 6 章：电穿孔仪器市场（依应用）

  • 蛋白质生产
  • 药物输送
  • 生物医学研究

第 7 章：电穿孔仪器市场（依最终用户划分）

  • 医院
  • 实验室
  • 生技及製药公司
  • 研究与学术机构
  • 其他的

第 8 章：电穿孔仪器市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第九章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第十章：公司简介

  • Bio-Rad Laboratories, Inc.
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 关键进展
    • SWOT 分析
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • MaxCyte
  • Lonza Group
  • BEX CO., LTD.
  • Celetrix, LLC.
  • Harvard Bioscience, Inc.
  • Bulldog Bio, Inc.
  • Spectrocell Inc.

第 11 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 12 章：附录

简介目录
Product Code: MD3818

The global electroporation instruments market reached US$ 251.42 million in 2024 and is expected to reach US$ 374.04 million by 2033, growing at a CAGR of 4.5% during the forecast period 2025-2033.

Electroporation instruments are devices used to facilitate electroporation, a technique that involves applying short electrical pulses to cells to temporarily increase the permeability of their membranes. This allows for the introduction of substances like DNA, RNA, proteins, or drugs into the cell, a process that is essential for various applications in biotechnology, genetic engineering, and medicine. Electroporation is widely used in genetic research, drug delivery, vaccination, and protein production, as it allows for more efficient and direct transfer of molecular substances into cells compared to traditional methods. The instruments are highly valued for their precision, effectiveness, and ability to handle a variety of cell types, including both eukaryotic and prokaryotic cells.

The electroporation instruments market is experiencing significant growth, driven by advancements in biotechnology, increased research activities, and the rising demand for gene editing and therapeutic applications. For instance, in June 2024, Porton Advanced introduced the MaxCyte cGMP-grade ExPERT GTx Flow Electroporation instrument to its cell therapy platform, marking the company as the first cell therapy CDMO in China to possess this clinical-grade flow electroporation system.

Market Dynamics: Drivers & Restraints

Rising technological advancements

The rising technological advancements are significantly driving the growth of the electroporation instruments market and are expected to drive the market over the forecast period. Electroporation has become a pivotal technique in cancer treatment, particularly through electrochemotherapy. This method involves applying electrical pulses to tumors, increasing cell membrane permeability and allowing chemotherapeutic agents to enter cancer cells more effectively. Technological advancements have improved the precision and safety of this technique, leading to better treatment outcomes for patients with cutaneous and subcutaneous tumors.

For instance, in October 2024, AngioDynamics with the University College London Hospital (UCLH) launched a prospective registry study evaluating the long-term effects of the NanoKnife system for treating unifocal intermediate-risk prostate cancer. This NanoKnife system uses irreversible electroporation technology to treat tumors by delivering high-voltage electrical pulses that create tiny pores in cell membranes, leading to controlled cell death without harming surrounding tissues.

The development of gene editing technologies, such as CRISPR-Cas9, has increased the demand for electroporation instruments. Electroporation facilitates the efficient delivery of gene-editing components into cells, thereby advancing research and therapeutic applications. This has led to a surge in the adoption of electroporation instruments in genetic engineering and therapeutic interventions.

The high cost of the electroporation instruments

The high cost of electroporation instruments significantly hampers the growth of the market by limiting accessibility and adoption, particularly among smaller laboratories and research institutions with constrained budgets. For instance, the cost of the new electroporation systems typically ranges from $3,000 to $20,000, depending on the model, features and capabilities.

The substantial expense of electroporation instruments restricts their acquisition to well-funded laboratories and research centers, leaving smaller institutions unable to invest in such technologies. This disparity results in unequal access to advanced research tools, hindering the overall growth of the market. High equipment costs can lead to delays in research projects and the development of new therapies, as institutions may lack the necessary resources to procure and maintain these instruments. This slowdown in research activities can impede scientific progress and innovation within the field.

Segment Analysis

The global electroporation instruments market is segmented based on product type, application, end-user and region.

Product Type:

The instruments segment is expected to dominate the electroporation instruments market share

In the electroporation instruments market, the instruments segment including total electroporation systems, eukaryotic electroporation systems and microbial electroporation systems holds a dominant position over the accessories segment. This dominance is primarily due to the essential role that electroporation systems play in the process, as they generate the electrical pulses necessary for cell membrane permeabilization.

These electroporation instruments are the core devices for researchers to transfect even the most difficult cell types with excellent efficiency, cell recovery, and repeatability and these instruments apply electrical pulses to cells, facilitating the introduction of substances like DNA, RNA, or drugs. The market for these systems is substantial, with projections indicating significant growth.

For instance, in April 2023, Thermo Fisher Scientific launched the Invitrogen Neon NxT Electroporation System, which allows researchers to transfect even the most difficult cell types with excellent efficiency, cell recovery, and repeatability. Neon NxT electrodes are ideally positioned and have a small surface area to provide a more uniform electric field and keep physiological parameters stable during transfection. These advantages allow the intended alteration to occur in more cells, with fewer cells lost during the transfection process. The new system also has an enhanced feedback loop and ergonomic advancements for ease of usage.

Geographical Analysis

North America is expected to hold a significant position in the electroporation instruments market share

North America especially the United States boosts a well-established healthcare system with state-of-the-art research laboratories, facilitating the adoption and integration of advanced technologies like electroporation instruments. The presence of major market players in the region particularly in the United States fosters innovations and advancements in electroporation instruments.

For instance, in March 2022, Thermo Fisher Scientific introduced a new large-volume electroporation system that allows cell therapy developers to more easily move from clinical development to commercial manufacturing. The Gibco CTS Xenon Electroporation System leverages a closed, highly flexible design to facilitate gene modifications without the use of traditional viral vectors. The electroporation approach enables the introduction of a payload into a cell by temporarily increasing cell permeability using an electrical pulse.

Asia-Pacific is growing at the fastest pace in the electroporation instruments market

The region is witnessing significant progress in biotechnology and molecular biology research. Electroporation instruments are essential for gene editing, protein production, and other biomedical applications. The expansion of research facilities and increased funding are contributing to the adoption of these technologies.

For instance, China has been leading investments in biotechnology with initiatives such as "Made in China 2025," which focuses on integrating advanced technologies into manufacturing and healthcare sectors. This initiative is expected to bolster the demand for electroporation instruments as part of broader biotechnological advancements.

As emerging economies in Asia-Pacific continue to develop their biotech sectors, there is an increasing demand for electroporation instruments for applications in biomedical research and therapeutic delivery56. Countries like India are investing heavily in science and technology, which further supports market growth

Competitive Landscape

The major global players in the electroporation instruments market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Merck KGaA, MaxCyte, Lonza Group, BEX CO., LTD., Celetrix, LLC., Harvard Bioscience, Inc., Bulldog Bio, Inc., Spectrocell Inc. and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global electroporation instruments market report delivers a detailed analysis with 62 key tables, more than 53 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Electroporation Instruments
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Electroporation Instruments Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Instruments*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Total Electroporation Systems
    • 5.2.4. Eukaryotic Electroporation Systems
    • 5.2.5. Microbial Electroporation Systems
  • 5.3. Accessories
    • 5.3.1. Electroporation Cuvettes
    • 5.3.2. Electrodes
    • 5.3.3. Chambers
    • 5.3.4. Kits
    • 5.3.5. Others

6. Electroporation Instruments Market, By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Protein Production*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Drug Delivery
  • 6.4. Biomedical Research

7. Electroporation Instruments Market, By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Laboratories
  • 7.4. Biotechnology and Pharmaceutical Companies
  • 7.5. Research and Academic Institutions
  • 7.6. Others

8. Electroporation Instruments Market, By Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
      • 8.2.6.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Brazil
      • 8.4.6.2. Argentina
      • 8.4.6.3. Rest of South America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Bio-Rad Laboratories, Inc.*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Financial Overview
    • 10.1.4. Key Developments
    • 10.1.5. SWOT Analysis
  • 10.2. Thermo Fisher Scientific Inc.
  • 10.3. Merck KGaA
  • 10.4. MaxCyte
  • 10.5. Lonza Group
  • 10.6. BEX CO., LTD.
  • 10.7. Celetrix, LLC.
  • 10.8. Harvard Bioscience, Inc.
  • 10.9. Bulldog Bio, Inc.
  • 10.10. Spectrocell Inc.

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us